Rhode Island HB 5094: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY (Requires the identification of prescription drugs on which the state spends significant health care dollars due to increase in costs and requires the drug's manufacturers to provide relevant information and documentation to justify costs increases.)

Status: 01/29/2019 Committee recommended measure be held for further study (as of 2019-01-29)

State: Rhode Island · Session: 2019 · Bill: HB 5094

Subjects: Business & Professions, Drugs

Sponsors: Hull, Lombardi, Walsh

View Rhode Island HB 5094 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.